Accessibility Menu
Healixa logo

Healixa(OTC) EMOR

Market Cap$29.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-94%
5 Year-91%
1 Year+320%
1 Month-16%
$0.04
-6.25%
-0.00Today
Healixa last closing stock price
MetricPriceDate
Last closeUSD 0.042026-08-12
Healixa stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.13%USD 0.042026-08-03
1 month-15.73%USD 0.052026-07-10
3 month-16%USD 0.052026-05-14
Year to date+320%USD 0.012025-12-30
1 year+320%USD 0.012025-08-12
3 year-80.47%USD 0.222023-08-11
5 year-90.67%USD 0.452021-08-12
Since inception-94.08%USD 0.712019-04-15

Healixa Financials at a Glance

Market Cap

$29.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$483.18K

Net Income (TTM)

-$859.34K

EPS (TTM)

-$0.00

P/E Ratio

-38.18

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Price

$0.04

Volume

26

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.01 - $0.07

Estimated Earnings Date

Sep 26, 2024

EMOR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Healixa

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. The company offers tech solutions to enterprise partner channels across various industries, including employer benefits, travel, pharma, and logistics. Healixa also runs a digital pharmacy marketplace.

Products and Services
  • Technology solutions for healthtech and fintech sectors
  • Digital pharmacy marketplace for streamlined access to medications
  • Enterprise solutions for industries like travel and logistics
Growth Outlook
  • Recent quarterly revenue reached $388,983, indicating potential for growth
  • Operating income improved to $26,757 in Q1 2025, showcasing operational efficiency
  • Strong gross profit margin of 69% in Q1 2025 suggests effective cost management
Financial Highlights
  • Market capitalization stands at approximately $30.67 million
  • Trailing twelve-month revenue of $1.4 million reflects growth potential
  • Current ratio of 0.007 indicates a need for improved liquidity management
Healixa Inc. has positioned itself at the intersection of healthtech and fintech, providing innovative solutions that cater to a diverse range of industries. The company's digital pharmacy marketplace is particularly noteworthy, as it addresses the growing demand for accessible healthcare solutions. Recent financial performance indicates a positive trajectory, with a significant revenue increase in the latest quarter. The operating income also reflects a move towards greater efficiency, which could enhance profitability in the future. Despite challenges in liquidity, as indicated by the current ratio, the company’s strong gross profit margin suggests that it is effectively managing its costs. The market capitalization of approximately $30.67 million positions Healixa as a potentially attractive investment opportunity within the technology sector. Overall, Healixa Inc. presents a compelling case for investors interested in the evolving landscape of healthtech and fintech solutions.
AI Generated • Aug 7, 2026

Industry

Health Care Technology

Employees

12

CEO

Ian Parker

Headquarters

Holbrook, NY 11741, US

EMOR Financials

Key Financial Metrics (TTM)

Gross Margin

77.38%

Operating Margin

-96.13%

Net Income Margin

-177.85%

Return on Equity

8.98%

Return on Capital

N/A

Return on Assets

-1224.25%

Earnings Yield

-2.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$29.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

712.12M

Volume

26

Avg. Volume

18.88K

Financials (TTM)

Gross Profit

$373.90K

Operating Income

-$464.47K

EBITDA

-$453.43K

Operating Cash Flow

-$246.02K

Capital Expenditure

$7.00

Free Cash Flow

-$246.01K

Cash & ST Invst.

$0.00

Total Debt

$6.69M

Healixa Performance Analysis

Healixa annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 15,092N/A
20242024-03-31USD 603,6813900.0%
20252025-03-31USD 702,90816.4%
20262026-03-31USD -94,442N/A
Healixa sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-03-312.6%
Q12025-06-30313.0%
Q22025-09-30-100.0%
Q32025-12-31N/A
Healixa annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.01180.0%
20242024-03-31USD -0.01-12.2%
20252025-03-31USD -0.00-88.4%
20262026-03-31USD -0.00-30.0%
Healixa sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-03-31-100.0%
Q12025-06-3075.0%
Q22025-09-30100.0%
Q32025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$29.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.15M

N/A

Employees

26

N/A

Net Income

-$225.08K

-58.9%

EBITDA

-$159.40K

-12.5%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$0.00

-100.0%

Total Debt

$6.69M

-4.9%

Accounts Receivable

$28.00K

-89.7%

Inventory

$21.71K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$6.69M

-4.9%

Return on Assets

-12.24%

N/A

Return on Invested Capital

4.78%

N/A

Free Cash Flow

-$8.82K

+89.4%

Operating Cash Flow

-$8.82K

+89.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBSVPharma-Bio Serv, Inc.
$0.54+0.00%
ALRTFALR Technologies Inc.
$0.02-3.39%
SPLTFSpotLite360 IOT Solutions, Inc.
$0.08+0.00%
VYNDVynleads, Inc.
$0.41+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About EMOR

What is the current price of Healixa?

Healixa is trading at $0.04 per share.

What is the 52-week range for Healixa?

Over the past 52 weeks, Healixa has traded between $0.01 and $0.07.

How much debt does Healixa have?

As of the most recent reporting period, Healixa reported total debt of $6.69M.

How much cash does Healixa have on hand?

Healixa reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Healixa’s dividend yield?

Healixa does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.